Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Stanulla

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study groupStefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Haematologica|August 22, 2015
Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylationJoachim B Kunz, Tobias Rausch, Obul R Bandapalli, et al.
Oncotarget|September 8, 2018
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissueMichael Forster, Adam Mark, Friederike Egberts, et al.
British Journal of Haematology|July 24, 2012
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsAndishe Attarbaschi, Maria Morak, Gunnar Cario, et al.
The Lancet. Oncology|July 25, 2017
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group studyBenjamin O Wolthers, Thomas L Frandsen, André Baruchel, et al.
Ebiomedicine|May 29, 2024
An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasiaMing Tang, Željko Antić, Pedram Fardzadeh, et al.
Haematologica|November 24, 2018
Trypsin-encoding <i>PRSS1-PRSS2</i> variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group reportBenjamin O Wolthers, Thomas L Frandsen, Chirag J Patel, et al.
Leukemia|March 14, 2021
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Anja Möricke, et al.
Blood|February 21, 2008
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Anja Möricke, Alfred Reiter, Martin Zimmermann, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study groupStefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Haematologica|August 22, 2015
Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylationJoachim B Kunz, Tobias Rausch, Obul R Bandapalli, et al.
Oncotarget|September 8, 2018
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissueMichael Forster, Adam Mark, Friederike Egberts, et al.
British Journal of Haematology|July 24, 2012
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsAndishe Attarbaschi, Maria Morak, Gunnar Cario, et al.
The Lancet. Oncology|July 25, 2017
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group studyBenjamin O Wolthers, Thomas L Frandsen, André Baruchel, et al.
Ebiomedicine|May 29, 2024
An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasiaMing Tang, Željko Antić, Pedram Fardzadeh, et al.
Haematologica|November 24, 2018
Trypsin-encoding <i>PRSS1-PRSS2</i> variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group reportBenjamin O Wolthers, Thomas L Frandsen, Chirag J Patel, et al.
Leukemia|March 14, 2021
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Anja Möricke, et al.
Blood|February 21, 2008
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Anja Möricke, Alfred Reiter, Martin Zimmermann, et al.
Pageof 15